A recent theory about the basis for fragile X syndrome is now validated in a mouse model. The findings point the way to treatment options targeting group 1 metabotropic glutamate receptors.

is concerned about the lack of awareness around Fragile X syndrome and about how common it is. “There is a surprising lack of awareness around Fragile X syndrome,” says Pete Richardson ...